Remove 2016 Remove Doctors Remove Healthcare Remove Prescription
article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

American healthcare is in trouble. I have to laugh when I hear that a pharma company is patient-centric because that’s become a slogan to make employees feel good about themselves while the costs of prescription drugs increase every year. Highest-paid CEOs in 2019: Who made the list from healthcare. This has to end.

article thumbnail

The best way to lower healthcare costs

World of DTC Marketing

percent in 2015-2016. Pharma should strive to get patients off some prescription drugs because they lost weight and are eating well, but we know that’s not going to happen. Research has shown that when some doctors tell patients to lose weight, many resort to “fast and dangerous” methods like OTC stimulants.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

Worldwide obesity rates have tripled since 1975, with 650 million adults obese in 2016, according to the World Health Organization. But before the company can make Wegovy mainstream, it has to convince doctors to prescribe it and insurers and governments to pay for it. In addition, doctors may not be ready to prescribe the drug.

article thumbnail

Health consumers: A long way off

World of DTC Marketing

We keep hearing the term “consumers of health” but the American healthcare system is too profitable to allow people to be consumers of healthcare. What if … people got a fair ROI for healthcare spending the way we expect a reasonable return from other investments? Except in healthcare. Shopping for healthcare?

article thumbnail

Katie Porter attacks pharma

World of DTC Marketing

2wo: The number of mergers and acquisitions(M&A) involving one of the top 25 firms in the pharmaceutical industry more than doubled from 2006 to 2016, and the practice doesn’t seem to be abating. The cost is estimated to be in the billions. By the way, Ms. Porter looks like she could lose some weight too.

Pharma 187
article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

In some ways, it is not difficult to understand why: healthcare faced unprecedented challenge from the COVID-19 pandemic and responded in an extraordinary way. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem.

Doctors 57